MPEG1/perforin-2 mutations in human pulmonary nontuberculous mycobacterial infections.
نویسندگان
چکیده
Perforin-2 is a highly conserved pore-forming protein encoded by macrophage expressed gene 1 (MPEG1). A number of studies have shown that Perforin-2-deficient mice are unable to survive following a bacterial challenge that is nonlethal in WT mice. There is also recent evidence that Mpeg1+/- heterozygous mice display an intermediate killing ability compared with Mpeg1 WT and Mpeg1-/- mice. Despite these in vivo findings, to date, no perforin-2 deficiencies have been associated with human disease. Here, we report four patients with persistent nontuberculous mycobacterial infection who had heterozygous MPEG1 mutations. In vitro, neutrophils, macrophages, and B cells from these patients were unable to kill Mycobacterium avium as efficiently as normal controls. CRISPR mutagenesis validated the deleterious antibacterial activity of these mutations. These data suggest that perforin-2 haploinsufficiency may contribute to human susceptibility to infections with intracellular bacteria.
منابع مشابه
Extraction and biological evaluation of Mycobacterium kansasii extracellular vesicles as a vaccine candidate against mycobacterial pulmonary infections
Introduction: Extracellular vesicles (EVs) are bacterial products with diverse biological roles. Like many microorganisms, Mycobacterium kansasii as a nontuberculous mycobacteria (NTM), can naturally release EVs. The aim of the present study was the extraction and biological evaluation of M. kansasii as a vaccine candidate against mycobacterial pulmonary infections. Methods: After bacterial cul...
متن کاملAdjuvant surgical treatment of nontuberculous mycobacterial lung disease.
BACKGROUND According to the 2007 American Thoracic Society/Infectious Diseases Society of America statement on nontuberculous mycobacterial diseases, more evidence for the benefits of adjuvant nontuberculous mycobacterial lung disease surgical intervention is needed before its wide application can be recommended. METHODS A retrospective review was conducted of 60 consecutive patients who met ...
متن کاملElevated serum CA 19-9 levels in patients with pulmonary nontuberculous mycobacterial disease.
Increased serum CA 19-9 levels in patients with nonmalignant diseases have been investigated in previous reports. This study evaluates the clinical significance of serum CA 19-9 elevation in pulmonary nontuberculous mycobacterial disease and pulmonary tuberculosis. The median CA 19-9 level was higher in patients with pulmonary nontuberculous mycobacterial disease than in patients with pulmonary...
متن کاملGuidelines for chemotherapy of pulmonary nontuberculous mycobacterial disease--2012 revised version.
In 2008, the Nontuberculous Mycobacteriosis Control Committee of the Japanese Society for Tuberculosis and the Scientifi c Assembly for Infection and Tuberculosis of the Japanese Respiratory Society (hereinafter, the Joint Guidelines Committee) published the Guidelines for chemotherapy of pulmonary nontuberculous mycobacterial disease─2008 interim guidelines 1). In the background, rifabutin (RB...
متن کاملNontuberculous Mycobacterial Infection in a Patient Diagnosed with Ankylosing Spondylitis
Nontuberculous mycobacteria are common microorganisms in nature and are particularly found in soil and water. They cause pulmonary infections, lymphadenitis, disseminated infections, localized skin and soft tissue infections, tendon–bone–articular infections, and catheter infections. Mycobacterium xenopi is categorized as a slow-growing mycobacterium. Pulmonary infections caused by M. xenopi ha...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- JCI insight
دوره 2 8 شماره
صفحات -
تاریخ انتشار 2017